COVID-19-associated fungal infections
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …
important complication in a substantial number of critically ill, hospitalized patients with …
When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis
TM John, CN Jacob, DP Kontoyiannis - Journal of fungi, 2021 - mdpi.com
Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries
Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …
Pathogenesis of respiratory viral and fungal coinfections
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
AJ Carlos, DP Ha, DW Yeh, R Van Krieken… - Journal of Biological …, 2021 - ASBMB
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
the COVID-19 global pandemic, utilizes the host receptor angiotensin-converting enzyme 2 …
the COVID-19 global pandemic, utilizes the host receptor angiotensin-converting enzyme 2 …
The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein
The current Coronavirus global pandemic necessitates the search for novel targets and
therapeutic avenues. Shaban et al. 1 reported the use of an endoplasmic reticulum (ER) …
therapeutic avenues. Shaban et al. 1 reported the use of an endoplasmic reticulum (ER) …
Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: a review and model making novel …
R Root-Bernstein - International journal of molecular sciences, 2021 - mdpi.com
Severe COVID-19 is characterized by a “cytokine storm”, the mechanism of which is not yet
understood. I propose that cytokine storms result from synergistic interactions among Toll …
understood. I propose that cytokine storms result from synergistic interactions among Toll …
Coronavirus disease 2019–associated mucormycosis: risk factors and mechanisms of disease
S Narayanan, JV Chua… - Clinical Infectious Diseases, 2022 - academic.oup.com
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review
A Jose, S Singh, A Roychoudhury, Y Kholakiya… - Journal of maxillofacial …, 2021 - Springer
Aim Recently, with the second wave of COVID-19, the Indian subcontinent has witnessed a
dramatic rise in mucormycosis infection in patients recovered from COVID-19. This …
dramatic rise in mucormycosis infection in patients recovered from COVID-19. This …